Jason Zemansky Stock Analyst Profile - B of A Securities Research Coverage - Stocknear

Jason Zemansky

Stock Analyst at B of A Securities

(4.57)
# 1433
Out of 5,478 analysts
48
Total ratings
Success rate
Average return
14 Stocks
Name Action PT Current % Upside Ratings Updated
HOWL Werewolf Therapeutic...
Maintains: Buy
9 8
1.43 459.44% 5 Aug 25, 2025
RCKT Rocket Pharmaceutica...
Upgrades: Buy
4 10
3.16 216.46% 2 Aug 20, 2025
INSM Insmed
Maintains: Strong Buy
94 109
145.93 -25.31% 10 Jun 11, 2025
KROS Keros Therapeutics
Downgrades: Neutral
32 18
15.66 14.94% 2 Jun 10, 2025
CYTK Cytokinetics
Maintains: Neutral
62 54
51.13 5.61% 4 Apr 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
29 31
23.47 32.08% 4 Apr 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
22 17
11.53 47.44% 5 Feb 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
36 29
8.19 254.09% 2 Nov 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
30 31
15.55 99.36% 3 Aug 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
3 3
2.84 -11.97% 5 Jun 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
391 23
9.81 134.45% 2 Dec 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
230
18.2 1163.74% 1 Jul 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
450 162
0.93 17319.35% 1 Feb 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
145 155
n/a n/a 2 Dec 13, 2021